Following Debiopharm’s decision to rely on AlpVision anti-counterfeiting solutions to protect their products against counterfeits, which was reported back in January 2011, two other main pharmaceutical producers of branded medicines have signed licences for roll-out of AlpVision’s covert digital solutions for product authentication. The worldwide deployment will take place in the course of 2011.
This confirms AlpVision as a leading provider of the pharmaceutical industry, helping branded product manufacturers to combat counterfeiting and to uncover market diversion and other frauds.
On April 3 2014, the European Commission published an updated version of the Tobacco Products Directive (2014/40/ EU), effectively repealing 2001/37/EC.
This document outlines exactly what the European Commission's revised Tobacco Products Directive means for brand owners.
Make an enquiry
Thank you for submitting the form. Your enquiry will be submitted to the company.